Photochemistry and Photobiology,
Год журнала:
2024,
Номер
unknown
Опубликована: Окт. 9, 2024
Photodynamic
therapy
(PDT)
effectively
kills
cancer
cells
and
initiates
immune
responses
that
promote
anticancer
effects
locally
systemically.
Primarily
developed
for
local
regional
cancers,
the
potential
of
PDT
systemic
antitumor
[in
situ
photo-vaccination
(ISPV)]
remains
underexplored.
This
study
investigates:
(1)
comparative
effectiveness
paclitaxel
(PTX)
prodrug
[Pc-(L-PTX)
Abstract
For
tumor
treatment,
the
ultimate
goal
in
therapy
is
to
eliminate
primary
tumor,
manage
potential
metastases,
and
trigger
an
antitumor
immune
response,
resulting
complete
clearance
of
all
malignant
cells.
Tumor
microenvironment
(TME)
refers
local
biological
environment
solid
tumors
has
increasingly
become
attractive
target
for
cancer
therapy.
Neutrophils
within
TME
gastric
(GC)
spontaneously
undergo
ferroptosis,
this
process
releases
oxidized
lipids
that
limit
T
cell
activity.
Enhanced
photodynamic
(PDT)
mediated
by
di‐iodinated
IR780
(Icy7)
significantly
increases
production
reactive
oxygen
species
(ROS).
Meanwhile,
neutrophil
ferroptosis
can
be
triggered
increased
ROS
generation
TME.
In
study,
a
liposome
encapsulating
both
inhibitor
Liproxstatin‐1
modified
photosensitizer
Icy7,
denoted
LLI,
inhibits
growth
GC.
LLI
internalizes
into
MFC
cells
generate
causing
immunogenic
death
(ICD).
Simultaneously,
liposome‐deliver
effectively
neutrophils.
LLI‐based
PDT
neutrophil‐targeting
immunotherapy
synergistically
boost
anti‐PD‐1
treatment
elicit
potent
systemic
response
with
abscopal
effects.
conclusion,
holds
great
GC
immunotherapy.
ACS Applied Nano Materials,
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 1, 2025
Despite
significant
clinical
breakthroughs
in
anti-tumor
immunotherapy,
its
therapy
efficiency
remains
hindered
by
insufficient
"cold"
tumor
immune
responses.
The
ample
reactive
oxygen
species
photodynamic
(PDT)
can
trigger
the
immunogenic
cell
death
(ICD)
pathway
for
arousing
system
and
realizing
immunotherapy.
But
inherent
hypoxic
microenvironment
(TME)
limits
PDT
efficacy.
To
simultaneously
reverse
TME
promote
ICD
pathway,
multi-in-one
nanostructure
(FAIC)
is
designed,
which
catalase
(CAT)
photosensitizer
(I-Cy5)
are
encapsulated
a
folate
receptor-targeting
liposome.
Due
to
endoplasmic
reticulum
(ER)-targeting
ability
of
I-Cy5,
H2O2
decomposition
catalytic
CAT,
cell-targeting
liposome,
severe
ER
stress
triggered
nano
FAIC
pathway.
As
result,
infiltration
cytotoxic
T
lymphocytes
promoted,
response
boosted.
design
corresponding
mechanism
provide
potential
way
realize
efficient
Advanced Healthcare Materials,
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 13, 2025
Abstract
In
situ
tumor
vaccines,
which
utilize
antigens
generated
during
treatment
to
stimulate
a
cancer
patient's
immune
system,
has
become
potential
field
in
immunotherapy.
However,
due
the
immunosuppressive
microenvironment
(ITME),
generation
of
is
always
mild
and
not
sufficient.
Tumor‐resident
intracellular
bacteria
have
been
identified
as
complete
component
contribute
creating
ITME.
Herein,
tumor‐resident
scavenger
designed
induce
enhanced
antitumor
photoimmunotherapy‐driven
vaccines
for
treating
hypoxic
tumors.
This
developed
by
integrating
photosensitizer
CyI
antibiotics
Doxycycline
(Doxy)
into
thermal‐sensitive
tumor‐derived
exosomes
fused
liposomes
(ECDL).
vitro
vivo
results
showed
that
ECDL
could
homologous
target
cells
restrict
respiration
mitochondrial
reduce
hypoxia,
thus
providing
continuous
oxygen
eliminate
both
bacteria,
ablating
primary
inhibiting
metastasis
recurrence.
Moreover,
eliminating
neutralizes
ITME
triggers
production
bacterial‐related
neoantigens,
further
strength
study
provided
versatile
effective
are
promising
local,
abscopal,
metastatic
treatment.
Photodynamic
therapy
and
photothermal
have
emerged
as
indispensable
modalities
to
treat
diseases.
However,
their
efficacy
is
hindered
by
the
substantial
light
scattering
within
tissues,
preventing
transmission
effectively
targeted
lesion
sites.
Various
existing
devices
aimed
at
mitigating
typically
exhibit
invasiveness
complexity.
In
this
work,
we
propose
an
approach
that
utilizes
a
portable
acoustic
holographic
optical
waveguide
device
mitigate
manipulating
refractive
index
tissues.
This
manipulation
allows
in
situ
modulation
of
scattered
light,
thereby
promoting
concentration
photon
energy.
We
demonstrated
can
medium
through
simulation
imaging
experiments.
Second,
both
photodynamic
experiments
enhance
rate
temperature
rise
singlet
oxygen
(1O2)
generation,
respectively.
It
foreseeable
versatility
overcoming
augment
outcomes
phototherapy,
offering
noninvasive,
portable,
robust
method.
Antioxidants,
Год журнала:
2025,
Номер
14(3), С. 258 - 258
Опубликована: Фев. 24, 2025
Oxidative
stress,
which
is
characterized
by
an
imbalance
between
reactive
oxygen
species
(ROS)
production
and
antioxidant
defenses,
has
critical
roles
in
the
initiation,
progression,
treatment
of
gastric
cancer.
On
one
hand,
excessive
ROS
accumulation
induces
oxidative
damage
cancer
cell
death.
other
moderate
levels
cause
genetic
mutations
dysregulation
signaling
pathways
to
promote
proliferation,
inflammation,
angiogenesis,
metastasis
Notably,
emerging
evidence
revealed
that
also
mediate
post-translational
modifications
(oxPTMs)
redox-sensitive
proteins,
can
directly
affect
protein
functions
regulate
redox
cells.
Therefore,
elucidating
regulatory
mechanisms
stress
holds
great
promise
identify
novel
therapeutic
targets
or
redox-targeting
strategies.
This
review
will
summarize
regulating
hallmarks
highlight
ROS-mediated
oxPTMs
In
addition,
we
discuss
strategies
targeting
for
cancer,
with
emphasis
on
use
bioactive
natural
products
nanomaterials.
Frontiers in Bioengineering and Biotechnology,
Год журнала:
2025,
Номер
13
Опубликована: Март 21, 2025
The
early
diagnosis
rate
of
gastric
cancer
is
low,
and
most
patients
are
already
at
an
advanced
stage
by
the
time
they
diagnosed,
posing
significant
challenges
for
treatment
exhibiting
high
recurrence
rates,
which
notably
diminish
patients’
survival
quality
life.
Therefore,
there
urgent
need
to
identify
methods
that
can
enhance
efficacy.
Nanomedicine,
distinguished
its
small
size,
targeting
specificity,
strong
biological
compatibility,
particularly
well-suited
address
toxic
side
effects
associated
with
current
diagnostic
therapeutic
approaches
cancer.
Consequently,
application
nanomedicine
delivery
systems
in
has
garnered
increasing
interest
from
researchers.
This
review
provides
overview
recent
advancements
use
nanomaterials
as
drugs
or
drug
research,
encompassing
their
applications
diagnosis,
chemotherapy,
radiotherapy,
surgery,
phototherapy,
explores
promising
prospects
Advanced Science,
Год журнала:
2025,
Номер
unknown
Опубликована: Апрель 11, 2025
Abstract
Small
cell
lung
cancer
(SCLC)
is
an
extremely
aggressive
and
highly
malignant
type
of
that
frequently
develops
resistance
recurrence
following
initial
treatment.
Paclitaxel
(PTX)
a
second‐line
therapeutic
option
for
SCLC
patients
with
to
first‐line
However,
its
clinical
application
limited
due
suboptimal
efficacy
the
risk
hypersensitivity
reactions.
To
address
these
challenges,
novel
strategy
employing
cationic
liposome‐based
biomimetic
drug
co‐delivery
system,
siPFKFB4/PRL
PTX
@RBCM‐cRGD,
which
simultaneously
delivers
paclitaxel
PFKFB4‐targeting
small
interfering
RNA
(siRNA)
cells
tissues
proposed.
These
findings
demonstrate
this
system
can
induce
ferroptosis
in
cells,
thereby
enhancing
their
sensitivity
paclitaxel.
Moreover,
It
promotes
infiltration
immune
secretion
cytokines
within
microenvironment,
effectively
activating
anti‐tumor
immunity.
When
combined
anti‐PD‐L1
antibodies,
it
further
potentiates
responses.
results
suggest
codelivery
not
only
induces
enhance
but
also
reprograms
potentiating
effects
immunotherapy
providing
promising
new
SCLC.
ACS Applied Bio Materials,
Год журнала:
2025,
Номер
unknown
Опубликована: Апрель 12, 2025
The
PEGylation
of
drug-carrying
nanoparticles
has
often
been
used
to
prolong
blood
circulation
and
improve
drug
deposition
at
tumor
sites.
Nevertheless,
the
PEG-rich
hydrophilic
surfaces
retard
release
payloads
internalization
therapeutic
by
cancer
cells,
thus
lowering
anticancer
efficacy.
To
boost
potency
combined
photodynamic
therapy
(PDT)
photothermal
(PTT)
against
melanoma
conquering
PEG
dilemma,
herein,
hybrid
PEGylated
chitosan-covered
polydopamine
(PDA)
(PCPNs)
with
acidity-elicited
detachment
ability
were
fabricated
as
carriers
IR780,
a
small-molecule
photosensitizer
for
PTT
PDT.
IR780@PCPNs
displayed
uniform,
solid-like
spherical
shape
sound
colloidal
stability.
Under
near-infrared
(NIR)
irradiation,
showed
prominent
conversion
efficiency
(ca.
54.6%),
robust
stability,
reduced
IR780
photobleaching,
sufficient
singlet
oxygen
(1O2)
production,
glutathione-depleting
ability.
Moreover,
environmental
pH
being
from
7.4
5.0
37
°C,
decreased
interactions
between
PCPNs
due
increased
protonation
phenolic
hydroxyl
residues
within
PDA
primary
amine
groups
chitosan
accelerated
species
IR780@PCPNs.
Importantly,
cellular
uptake
B16F10
was
remarkably
promoted
in
weakly
acidic
milieu
upon
driven
disintegration
acid-labile
benzoic
imine.
With
NIR
internalized
generated
hyperthermia
1O2
damage
mitochondria,
thereby
effectively
inhibiting
proliferation
cells.
Collectively,
our
findings
present
practical
strategy
amplifying
efficacy
PDT
using
PEG-detachable
Biomedicines,
Год журнала:
2025,
Номер
13(4), С. 950 - 950
Опубликована: Апрель 12, 2025
Immunogenic
cell
death
(ICD)
is
a
promising
cancer
therapy
where
dying
tumor
cells
release
damage-associated
molecular
patterns
(DAMPs)
to
activate
immune
responses.
Recent
research
highlights
the
critical
role
of
metabolic
reprogramming
in
cells,
including
Warburg
effect,
oxidative
stress,
and
lipid
metabolism,
modulating
ICD
shaping
microenvironment.
These
changes
enhance
activation,
making
tumors
more
susceptible
surveillance.
This
review
explores
mechanisms
linking
mitochondrial
endoplasmic
reticulum
(ER)
ferroptosis.
It
also
discusses
innovative
therapeutic
strategies,
such
as
personalized
combination
therapies,
inhibitors,
targeted
delivery
systems,
improve
efficacy.
The
future
immunotherapy
lies
integrating
activation
overcome
evasion,
with
multi-omics
approaches
microbiome
modulation
offering
new
avenues
for
enhanced
treatment
outcomes.